DANA MARINO: Open Payments
NPI 1295982536 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$624 in 30 payments from 16 companies in 2025. Trend: 2023 $663 · 2024 $820 · 2025 $624
Food & beverage: $624
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $100 |
| PFIZER INC. | 3 | $75 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| ABBVIE INC. | 2 | $42 |
| Novo Nordisk Inc | 2 | $41 |
| Lilly USA, LLC | 2 | $36 |
| Janssen Pharmaceuticals, Inc | 1 | $35 |
| Amgen Inc. | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
Products named: AIRSUPRA, Auvelity, REXULTI, TRELEGY ELLIPTA, Ozempic, MOUNJARO, SPRAVATO, EVENITY.
Industry payments across CA — which companies pay providers there.
